CStone Pharmaceuticals Company
CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide.
Technology:
Biologics
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
China
Founded Date:
2015
Employees Number:
101-250
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Register and Claim Ownership